Myeloproliferative disease

Search with Google Search with Bing
Information
Disease name
Myeloproliferative disease
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT01167166 Completed Phase 1/Phase 2 Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL) July 2010 June 2014
NCT02308787 Completed Retrospective Data Collection of Routine Use With Spectra Optia® for Platelet Depletions November 2014 May 2015
NCT01394640 Completed Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients October 2009 January 2011
NCT00665067 Completed Correlative Biomarker Study in Patients With Myeloproliferative Disorders April 2007 July 20, 2018
NCT05553873 Recruiting Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study. September 8, 2022 December 2026
NCT01758042 Recruiting N/A Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders November 2012 July 2027
NCT01749111 Terminated Phase 3 Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis December 2012 August 2016
NCT01884974 Unknown status A Case Control Study of the Prevalence of Pulmonary Hypertension in Patients With Myeloproliferative Diseases. July 2013
NCT01800643 Unknown status Phase 2/Phase 3 Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation March 2010 December 2014